Amphastar Pharmaceuticals (STU:29A) Price-to-Tangible-Book : 31.34 (As of May. 29, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Amphastar Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-29), Amphastar Pharmaceuticals's share price is €38.55. Amphastar Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €1.23. Hence, Amphastar Pharmaceuticals's Price to Tangible Book Ratio of today is 31.34.

The historical rank and industry rank for Amphastar Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

STU:29A' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.8 Med: 2.78 Max: 113.69
Current: 31.34

During the past 13 years, Amphastar Pharmaceuticals's highest Price to Tangible Book Ratio was 113.69. The lowest was 1.80. And the median was 2.78.

STU:29A's Price-to-Tangible-Book is ranked worse than
97.09% of 860 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs STU:29A: 31.34

A closely related ratio is called PB Ratio. As of today, Amphastar Pharmaceuticals's share price is €38.55. Amphastar Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was €12.67. Hence, Amphastar Pharmaceuticals's P/B Ratio of today is 3.04.

Amphastar Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Amphastar Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Price-to-Tangible-Book Chart

Amphastar Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.54

2.51

2.61

2.74

109.44

Amphastar Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.41	-	-	109.44	31.87

Competitive Comparison of Amphastar Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amphastar Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Price-to-Tangible-Book falls into.

Amphastar Pharmaceuticals Price-to-Tangible-Book Calculation

Amphastar Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	38.55	/	1.23
	=	31.34

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Amphastar Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals (STU:29A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (STU:29A) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

AMPH:USA

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

http://www.amphastar.com

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals (STU:29A) Headlines

No Headlines